Evidence map›Paper›PMID 41063131›Full record

ArticleAIDS research and therapy2025

Antiretroviral therapy clients' experience of Follow-up care in tshwane, Gauteng province, South Africa.

Kulani James Mabasa, Sibusiso Zuma

Abstract read
In one paragraph

Article in AIDS research and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kulani James MabasaDepartment of Health Studies, University of South Africa, Pretoria, South Africa.
Sibusiso ZumaDepartment of Health Studies, University of South Africa, Pretoria, South Africa. ezumas@unisa.ac.za.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccess to antiretroviral therapy (ART) has improved substantially in resource-limited settings in Africa, Asia, and South America, where 90% of people living with human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS) reside. Despite the effective roll-out of free life-prolonging antiretroviral therapy (ART) in public clinics of South Africa since 2004 and the proven efficacy of ART, some people living with HIV (PLHIV) become lost to follow-up (LTFU) from treatment for various reasons. This study aimed to explore and describe the follow-up care experiences of clients on antiretroviral therapy in South Africa.

methodsThe researcher selected a qualitative research approach, used an exploratory and descriptive research design, collected data using in-depth unstructured interviews, and analysed data using thematic analysis. The ART clients were selected using purposive sampling, and data were collected from a sample of fifteen individuals at a primary healthcare facility to a point of data saturation.

resultsThe study revealed two categories of findings, personal experiences and healthcare services experiences. On a personal level, ART clients experienced fear of disclosing HIV status, stigma, increased non-adherence to HIV treatment influenced by alcohol use, communication problems with healthcare providers, medication side effects, and challenges with transportation to access primary healthcare (PHC) facilities. The healthcare systems were negatively experienced due to factors such as prolonged waiting times, a shortage of healthcare providers, staff attitude, facility operating hours, and a lack of integration in clinical healthcare services.

conclusionThe study showed that ART clients choose alternative treatment sites where they receive better services, including non-biomedical settings.

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsHIV InfectionsAdultFemaleFollow-Up StudiesHumansLost to Follow-UpMaleMedication AdherenceMiddle AgedQualitative ResearchSouth AfricaAnti-HIV AgentsAnti-Retroviral AgentsAntiretroviral therapyART regimensClient experienceFollow-up careHIVLoss to follow-upNon-adherenceNon-biomedicalPrimary healthcareStigma

Identifiers

PMID41063131
PMCPMC12505667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.